Actively Recruiting
Wearable Sensors for Delirium Detection at an Early Stage (WeSen_delirium)
Led by University of Zurich · Updated on 2024-05-10
72
Participants Needed
2
Research Sites
148 weeks
Total Duration
On this page
Sponsors
U
University of Zurich
Lead Sponsor
K
Klinik Hirslanden, Zurich
Collaborating Sponsor
AI-Summary
What this Trial Is About
Delirium is an acute brain-organic syndrome: its clinical manifestation and form are results of a highly complex pathophysiology. Delirium is a serious clinical problem in hospitalized adults. It is the most common neuropsychiatric complication of hospitalization and is associated with high patient burden, increased morbidity and mortality, prolonged length of stay, higher costs, and institutionalization. An early, accurate diagnosis as well as an adequate management are critical to the continued health and functional independence of the affected patients. Prevention strategies contain pharmacological and non-pharmacological interventions. However, their clinical success (effectiveness) is limited and the evidence for the use of pharmacological interventions for the prevention or management of delirium is scarce. The prediction of delirium has become a new promising topic in clinical research. New approaches like the implementation of wearable sensors, in particular wearable accelerometer devices to record movements related to delirium are promising. In this study, the study procedure only includes wearing a consumer-grade sensor on the wrist of the not-dominant hand. This way, vital parameters are measured in order to identify patterns.
CONDITIONS
Official Title
Wearable Sensors for Delirium Detection at an Early Stage (WeSen_delirium)
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Female and male inpatients aged 65 years or older
- Cognitive ability to understand, consent to and participate in the study
- Fluent in German
- Provision of written informed consent
You will not qualify if you...
- Presence of acute delirium
- Delirium diagnosis made within the last 4 weeks prior to hospitalization
- Likelihood of an alcohol withdrawal delirium (CAGE Score >1)
- Limited knowledge of the German language
- Dementia with Mini Mental Status Test Score 24 or lower
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 2 locations
1
Klinik Hirslanden
Zurich, Switzerland
Actively Recruiting
2
University Hospital Zurich, Internal Medicine
Zurich, Switzerland
Actively Recruiting
Research Team
M
Martina Kleber, PD Dr.
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
0
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here